Lopez J, Latta M, Collet X, Vanloo B, Jung G, Denefle P, Rosseneu M, Chambaz J
URA CNRS 1283, Institut des Cordeliers, Paris, France.
Eur J Biochem. 1994 Nov 1;225(3):1141-50. doi: 10.1111/j.1432-1033.1994.1141b.x.
We have expressed recombinant human apolipoprotein A-II (apoA-II) in Escherichia coli, as a fusion protein with Schistosoma japonicum glutathione-S-transferase (GST). The GST-AII fusion protein was recovered by affinity chromatography using glutathione as a ligand. After thrombin cleavage and removal of the GST carrier, recombinant apoA-II was obtained in a highly purified form and was exclusively composed of dimeric apoA-II. Kinetics of association to dimyristoylglycerophosphocholine (Myr2GroPCho) vesicles showed that recombinant apoA-II exhibited the same pattern of association as human plasma apoA-II. Electron microscopic analysis of the complexes showed a typical pattern of rouleaux, characteristic of stacked discs, with a diameter similar to that determined by gradient-gel electrophoresis. Circular dichroism measurements showed that the alpha-helical content of both plasma and recombinant apoA-II increased similarly when the proteins associated with Myr2GroPCho vesicles, at the expense of a random-coil structure. Lipid-bound apoA-II consisted of 70-72% alpha helices, suggesting the presence of three 18-residue alpha helices/apoA-II monomer. Cross-linking experiments indicated that Myr2GroPCho complexes contained two molecules dimeric apoA-II/vesicle. Recombinant apoA-II was as efficient as plasma apoA-II in associating with HDL subclasses, and in displacing apoA-I from dipalmitoylglycerophosphocholine/cholesterol/apoA-I complexes, most likely due to its highly ordered secondary structure when associated with Myr2GroPCho vesicles. These findings demonstrate that recombinant apoA-II exhibits the same structural and functional properties as human plasma apoA-II. Thus, the expression system utilized is appropriate to produce mutagenized forms to further structure/function analysis.
我们已在大肠杆菌中表达了重组人载脂蛋白A-II(apoA-II),它是与日本血吸虫谷胱甘肽-S-转移酶(GST)融合的蛋白。利用谷胱甘肽作为配体,通过亲和层析回收GST-AII融合蛋白。经凝血酶切割并去除GST载体后,获得了高度纯化的重组apoA-II,且其仅由二聚体apoA-II组成。与二肉豆蔻酰甘油磷酸胆碱(Myr2GroPCho)囊泡结合的动力学表明,重组apoA-II表现出与人类血浆apoA-II相同的结合模式。对复合物的电子显微镜分析显示出典型的缗钱状模式,这是堆叠圆盘的特征,其直径与梯度凝胶电泳测定的直径相似。圆二色性测量表明,当蛋白质与Myr2GroPCho囊泡结合时,血浆和重组apoA-II的α-螺旋含量以牺牲无规卷曲结构为代价而类似地增加。脂质结合的apoA-II由70 - 72%的α-螺旋组成,表明每个apoA-II单体存在三个18个残基的α-螺旋。交联实验表明,Myr2GroPCho复合物包含两个二聚体apoA-II分子/囊泡。重组apoA-II在与高密度脂蛋白亚类结合以及从二棕榈酰甘油磷酸胆碱/胆固醇/apoA-I复合物中置换apoA-I方面与血浆apoA-II一样有效,这很可能是由于其与Myr2GroPCho囊泡结合时具有高度有序的二级结构。这些发现表明,重组apoA-II表现出与人类血浆apoA-II相同的结构和功能特性。因此,所使用的表达系统适合产生诱变形式以进行进一步的结构/功能分析。